The enzymatic extraction method has a mild effect, but the enzymatic cost is high, the reaction time is long, and the process conditions (pH, temperature) are strictly controlled, so the cost-effectiveness in large-scale production needs to be improved (Binliang and Zhou, 2006)
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
psyllium-based supplements typically produce modest, low single-digit weight losses over months while GLP-1 medications like Ozempic (injectable) commonly produce double-digit average losses in human clinical trials
Compounded option for higher-intensity weight management